Stocktoria

GOLDENWELL BIOTECH, INC. GWLL

OTC · stock · Food and Kindred Products · website · IPO 2021-12-07

GOLDENWELL BIOTECH, INC. financials (annual, from 10-K)

Revenue
201920202021202220232024
Net income
201920202021202220232024
Free cash flow
201920202021202220232024

Bars are annual figures from 2019 to 2024; red bars are negative (a loss or cash outflow).

MetricFY2024FY2023FY2022FY2021FY2020FY2019
Revenue$139$2,340$47,800$15,967$0$0
Gross profit$64$666$25,186$8,388$0$0
SG&A expense$126,655$6,368$2,601
Operating income-$123,098-$115,826-$985,105-$118,267
Interest expense$8,400$1,535$0$0$0
Income tax$0$0$0$0$0$0
Net income-$131,498-$117,361-$985,097-$116,981-$6,324-$2,311
EPS (diluted)$0.00$0.00
Operating cash flow-$123,077-$113,153-$1.1M-$205,138-$6,324-$2,311
Cash & equivalents$53,231$45,996$213,556$248,569$246,593
Inventory$174,788$174,863$176,058$198,671$0
Total assets$224,192$228,094$248,400$460,979$248,569$246,593
Total liabilities$271,433$143,837$46,782$159,266$0$0
Shareholders' equity-$47,241$84,723$201,618$301,713$248,569$246,593

Growth · year-over-year

MetricFY2024FY2023FY2022FY2021FY2020FY2019
Revenue growth-94.1%-95.1%+199.4%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Source: SEC EDGAR filings · CIK 0001800373 · US · as of 2024-12-31. facts plus Stocktoria's own computed scores — not investment advice.